Jane Street’s SOPHiA GENETICS SOPH Stock Holding History

Jane Street’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,091	Closed	-$80K	–	9517
2023 Q1	$80K	Buy	+16,091	New	+$52.1K	﹤0.01%	8320

Other funds holding SOPH

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AWA

Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BPCE

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Jane Street's SOPH Position: Q2 2023 in Review

Jane Street sold out of SOPHiA GENETICS (SOPH) in Q2 2023, closing a stake of 16,091 shares — an estimated $80K sold.

Jane Street first reported a position in SOPH in Q1 2023 and held it in 1 quarter. The position peaked at $80K in Q1 2023. 34 funds tracked by Wall St. Rank hold SOPH as of Q2 2023.

Jane Street reported no remaining SOPHiA GENETICS position as of Q2 2023 after selling out during the quarter.
Jane Street sold 16,091 SOPHiA GENETICS shares in Q2 2023, an estimated $80K.
Jane Street first reported a position in SOPHiA GENETICS in Q1 2023 and held it in 1 quarter.
Jane Street's SOPHiA GENETICS position peaked at $80K in Q1 2023.
34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.